🔗 Share this article

Chancellor Reeves has stated she is planning "targeted measures to deal with cost of living challenges" in the upcoming Budget.

Speaking to media outlets, she noted that reducing inflation is a collective task of both the government and the central bank.

The UK's inflation rate is expected to be the most elevated among the G7 advanced economies this calendar year and next.

Potential Energy Cost Interventions

Reports indicate the administration could take action to reduce utility costs, such as by slashing the current 5% rate of value-added tax charged on energy supplies.

Another possibility is to reduce some of the policy costs presently added to bills.

Fiscal Constraints and Expert Predictions

The administration will obtain the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much space there is for such actions.

The consensus from most economists is that the Chancellor will have to announce tax increases or budget cuts in order to adhere to her voluntary fiscal targets.

Previously on the same day, estimates suggested there was a £22 billion gap for the Treasury chief to fill, which is at the more modest range of forecasts.

"There's a shared responsibility between the central bank and the government to continue tackling some of the sources of inflation," Reeves informed the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.

Tax Commitments and International Issues

While a great deal of the attention has been on likely tax increases, the Treasury chief said the latest data from the fiscal watchdog had not changed her pledge to campaign commitments not to increase rates on earnings tax, VAT or social security contributions.

She attributed an "unpredictable world" with rising geopolitical and commercial issues for the fiscal revenue measures, probably to be directed on those "with the broadest shoulders."

International Economic Tensions

Commenting on worries about the UK's economic relations with the Asian nation she said: "The UK's national security invariably are paramount."

Last week's announcement by Chinese authorities to strengthen export controls on critical minerals and other materials that are essential for high-technology production led US President Donald Trump to suggest an additional 100% import tax on imports from China, raising the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary described the Chinese action "commercial pressure" and "a international production control attempt."

Questioned on considering the US offer to participate in its battle with China, the Chancellor said she was "extremely troubled" by Chinese measures and urged the Chinese government "not to put up barriers and restrict access."

She said the move was "harmful for the international commerce and generates additional challenges."

"I believe there are fields where we need to address China, but there are also significant prospects to export to China's economy, including banking sector and other areas of the economic system. We've got to get that balance right."

The chancellor also affirmed she was cooperating with international partners "regarding our own critical minerals strategy, so that we are more independent."

Health Service Drug Costs and Investment

Reeves also acknowledged that the cost the NHS spends on medicines could rise as a consequence of current talks with the Trump administration and its drugs companies, in exchange for lower tariffs and investment.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or abandoning investments in the United Kingdom, with some blaming the insufficient payments they are obtaining.

Last month, the Science Minister said the cost the health service spends on medicines would must rise to halt firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor told the BBC: "It has been observed as a result of the payment system, that clinical trials, recent pharmaceuticals have not been provided in the UK in the way that they are in other European countries."

"We want to ensure that patients getting treatment from the National Health Service are able to access the best critical medicines in the world. And so we are reviewing all of that, and... looking to secure increased investment into Britain."